Cramer Rosenthal Mcglynn LLC Elanco Animal Health Inc Transaction History
Cramer Rosenthal Mcglynn LLC
- $1.77 Billion
- Q1 2024
A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 493,846 shares of ELAN stock, worth $7.02 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
493,846Holding current value
$7.02 Million% of portfolio
0.45%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
408Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.19 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$752 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.3MShares$700 Million0.02% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$379 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22.1MShares$315 Million0.04% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.74B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...